查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2004881

醫用注射射出成型市場：2026-2032年全球市場預測（按產品類型、材料類型、製程類型、應用和最終用戶分類）

Medical Injection Molding Market by Product Type, Material Type, Process Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療射出成型市場價值將達到 257.4 億美元，到 2026 年將成長至 274.4 億美元，到 2032 年將達到 389.8 億美元，複合年成長率為 6.10%。

主要市場統計數據
基準年 2025 257.4億美元
預計年份：2026年 274.4億美元
預測年份 2032 389.8億美元
複合年成長率 (%) 6.10%

本文全面說明了更嚴格的法規、材料創新和精密製造的融合如何重塑醫療射出成型。

醫療射出成型產業處於精密工程、嚴格法律規範和快速變化的臨床需求三者交匯的十字路口。材料、製程控制和器械設計的進步提高了對公差、生物相容性和滅菌合規性的要求，促使製造商追求設計與生產的更緊密結合。同時，全球供應鏈壓力和細微的區域監管差異使得穩健的籌資策略和供應商認證通訊協定至關重要。

技術現代化、材料進步和法規加速發展正在改變工業製造策略—一項富有洞察力的分析。

近年來，在技術創新、日益嚴格的法規和不斷變化的臨床需求的推動下，醫用射出成型領域經歷了變革性的變化。自動化和工業4.0技術已從試生產線推廣到生產車間，實現了更高的重複性、即時監控和整合品管。這些能力能夠滿足現代導管、植入式組件和藥物輸送裝置日益複雜的幾何形狀和更嚴格的尺寸公差要求。

對累積關稅趨勢將如何影響採購多元化、本地生產投資和供應商選擇策略進行分析評估。

對於在全球醫療設備零件價值鏈中運作的製造商和採購經理而言，關稅政策和貿易措施至關重要。近期的關稅環境正在影響採購決策、資本投資和區域生產策略。各公司正透過審查其供應商網路，並探索近岸外包和本地化等方式來應對，以降低跨境成本波動和前置作業時間不確定性。

整合細分智慧，揭示產品類型、材料科學、應用、最終用戶環境和製程選擇如何相互關聯並驅動製造策略。

在將生產能力與產品和臨床需求相匹配時，對市場區隔的精準理解至關重要。產品類型的差異非常重要，因為導管和診斷組件的精確度和監管要求與給藥裝置和植入不同，而手術器械（無論是一次性的還是可重複使用的）則需要考慮其可重複使用性和滅菌性。此外，注射器和給藥組件需要特定的成型技術來維持流體公差和表面光潔度，這直接影響患者安全和給藥準確性。

一份策略性區域分析報告，概述了美洲、歐洲、中東和非洲以及亞太地區的趨勢如何影響生產地點、供應商策略和監管方法。

區域趨勢在製定製造策略和產業計畫繼續發揮決定性作用。美洲地區呈現出複雜的環境，既擁有先進的製造能力，又集中了臨床需求，同時法律規範也強調合規性和透明度。市場參與企業將接近性關鍵醫療系統以及國內或近岸生產帶來的物流優勢視為降低風險和加快產品上市速度的策略工具。

一份詳細的競爭分析報告，闡述了材料專業知識、檢驗的製程和供應連續性如何決定差異化和供應商選擇趨勢。

醫療射出成型領域的競爭格局呈現出兩極化的態勢：既有高度專業化的細分市場企業，也有提供從可製造性設計到檢驗生產和供應的全流程服務的大規模綜合性契約製造(CMO)。主要企業憑藉其先進材料技術、微成型技術、多成分整合以及經過驗證的合規流程等優勢脫穎而出，從而縮短客戶的檢驗週期。有些公司擅長生產監管嚴格的植入式組件，而有些公司則專注於注射器和一次性手術器械等大批量一次性組件。

為高階主管提供最佳化設計一致性、自動化投資、供應商多元化、跨職能協作和人才能力的實用建議。

產業領導企業應優先採取一系列切實可行的措施，以確保競爭優勢和業務永續營運。首先，他們應儘早使產品設計和材料選擇與生產能力相匹配，確保從概念階段到檢驗階段都融入生物相容性、耐滅菌性和設計工廠化生產（DFM）原則。早期匹配可以減少返工，縮短開發週期，並在規模化生產過程中提高產量比率。

詳細描述了一種嚴謹的三角調查方法，該方法結合了對關鍵相關人員的訪談、技術文獻的審查以及透過案例研究檢驗。

本研究的綜合分析是基於三角測量法得出的洞見，該方法結合了與關鍵相關人員的對話、技術文件分析以及與實際營運案例研究的交叉參考。關鍵對話包括與製造負責人、品質和法規專家以及產品開發團隊進行結構化訪談，以獲取關於材料選擇、工藝能力和供應鏈壓力的第一手觀點。透過這些對話，我們更深入地了解了影響成型策略的營運限制和決策標準。

結論強調，一體化製造、監管準備和供應彈性對於支持未來的醫療設備創新至關重要。

先進的注塑工藝、不斷豐富的材料選擇以及日益嚴格的監管要求，共同塑造了當前醫療射出成型的發展方向。那些積極採用流程自動化、投資於檢驗的品質體系，並將材料選擇與滅菌和臨床要求相匹配的企業，將更有能力應對供應鏈的不確定性，並滿足不斷變化的性能要求。同時，靈活的採購和區域生產策略能夠降低與貿易政策和物流相關的外部風險。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫用射出射出成型市場：依產品類型分類

  • 導管
  • 診斷部件
  • 藥物輸送裝置
  • 植入
  • 手術器械
    • 免洗設備
    • 可重複使用設備
  • 注射器

第9章 醫用射出射出成型市場：依材料類型分類

  • 彈性體
  • 矽酮
  • 熱塑性樹脂
    • 聚碳酸酯
    • 聚醚醚酮
    • 聚乙烯
    • 聚丙烯
    • 聚苯乙烯
  • 熱固性樹脂

第10章：依製程分類的醫用射出射出成型市場

  • 嵌件成型
  • 微型射出成型
  • 多成分模塑
  • 標準射出成型

第11章 醫用射出射出成型市場：依應用領域分類

  • 診斷
  • 藥物輸送
    • 自動注射器
    • 點滴筒
    • 預填充式注射器
  • 外科
  • 治療產品

第12章 醫用射出射出成型市場：依最終用戶分類

  • 門診部
  • 診斷檢查室
  • 居家醫療
  • 醫院

第13章 醫用射出射出成型市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫用射出射出成型市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 醫用射出射出成型市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫療射出射出成型市場

第17章：中國醫用射出射出成型市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accumold LLC
  • Alpine Mold Co Ltd
  • AptarGroup Inc
  • Becton, Dickinson and Company
  • BMP Medical
  • Currier Plastics Inc
  • Freudenberg Medical
  • Gerresheimer AG
  • Kaysun Corporation
  • Nolato MediTech AB
  • Plastikon Inc
  • Rochling Medical SE & Co KG
  • Seasky Medical Co Ltd
  • SMC Ltd
  • Spectrum Plastics Group
  • Sterling Industries Inc
  • Terumo Corporation
  • TPI Plastics Inc
  • Viant Medical Corporation
  • West Pharmaceutical Services Inc
Product Code: MRR-742BD518128B

The Medical Injection Molding Market was valued at USD 25.74 billion in 2025 and is projected to grow to USD 27.44 billion in 2026, with a CAGR of 6.10%, reaching USD 38.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 25.74 billion
Estimated Year [2026] USD 27.44 billion
Forecast Year [2032] USD 38.98 billion
CAGR (%) 6.10%

Comprehensive introduction framing the convergence of regulatory rigor, material innovation, and precision manufacturing reshaping medical injection molding

The medical injection molding sector stands at the intersection of precision engineering, stringent regulatory oversight, and rapidly evolving clinical requirements. Advances in materials, process controls, and device design have elevated expectations for tolerances, biocompatibility, and sterilization compatibility, driving manufacturers to pursue tighter integration between design and production. At the same time, global supply chain pressures and localized regulatory nuance have placed a premium on resilient sourcing strategies and supplier qualification protocols.

Consequently, executives are recalibrating priorities: investments in automation, quality management systems, and advanced materials selection are being evaluated against time-to-market and total cost of ownership considerations. Regulatory pathways continue to demand demonstrable process capability and traceability, prompting closer collaboration between regulatory, clinical, and manufacturing functions. Moreover, product complexity has grown as minimally invasive and drug delivery devices proliferate, requiring multi-material, multi-component molding solutions.

In this environment, leaders benefit from a structured view of how technical capability, compliance readiness, and supply-chain strategy coalesce to affect product commerciality. The following analysis synthesizes transformative shifts, policy impacts, segmentation intelligence, regional dynamics, competitive positioning, and practical recommendations to guide strategic decision-making in medical injection molding.

Insightful exploration of technological modernization, material evolution, and regulatory acceleration transforming manufacturing strategies in the industry

Over recent years the landscape of medical injection molding has undergone transformative shifts driven by technological innovation, regulatory tightening, and evolving clinical needs. Automation and Industry 4.0 technologies have migrated from pilot lines to production floors, enabling higher repeatability, real-time monitoring, and integrated quality controls. These capabilities support increasingly complex geometries and tighter dimensional tolerances required by modern catheters, implantable components, and drug delivery mechanisms.

Material science advancements have introduced a wider palette of biocompatible elastomers and high-performance thermoplastics, including polycarbonate and polyetheretherketone, which allow designers to reconcile mechanical performance with sterilization resilience. Concurrently, multi-component molding and micro injection molding have matured to accommodate drug delivery assemblies such as auto-injector housings and pre-filled syringe components, reducing assembly steps and exposure risks.

Regulatory expectations now emphasize process validation, traceability, and demonstrable control of particulate and extractables, accelerating adoption of automated inspection and data-driven quality assurance. Supply-chain resilience has moved to the forefront; nearshoring and diversified supplier networks are being considered to mitigate disruption and to comply with evolving trade and tariff policies. Taken together, these shifts are promoting a more integrated, quality-centric, and technologically enabled manufacturing model for medical devices.

Analytical assessment of how cumulative tariff developments drive sourcing diversification, localized production investments, and supplier qualification strategies

Tariff policies and trade measures have become a material consideration for manufacturers and procurement leaders operating in global value chains for medical device components. Recent tariff environments have influenced sourcing decisions, capital investments, and regional production footprint strategies. Firms have responded by reassessing supplier networks, considering nearshoring or regionalization to reduce exposure to cross-border cost volatility and lead-time uncertainty.

As a result, organizations are increasingly weighing the trade-offs between cost efficiency and supply continuity. Investment choices in automation and localized production can mitigate recurring tariff effects by lowering dependence on imported subassemblies and by enabling faster response to regulatory or clinical changes. Furthermore, longer qualification timelines for new suppliers have prompted companies to place higher value on established, audited partners with demonstrated compliance histories.

Procurement functions are therefore evolving from transactional buying toward strategic supplier relationship management, emphasizing contractual protections, dual sourcing strategies, and visibility into upstream material availability. In parallel, product design teams are re-evaluating material and process specifications to enable flexibility in sourcing. This cumulative effect of tariff-driven strategic realignment supports a more resilient and adaptable manufacturing posture across device lifecycles.

Integrated segmentation intelligence revealing how product typologies, material science, applications, end-user settings, and process choices interrelate to drive manufacturing strategy

A nuanced understanding of market segmentation is essential when aligning manufacturing capabilities to product and clinical needs. Product type distinctions matter because the precision and regulatory requirements for catheters and diagnostic components diverge from those for drug delivery devices and implants, while surgical instruments demand considerations around reusability and sterilization for both disposable and reusable instrument families. Syringes and drug delivery assemblies require specific molding approaches to maintain fluidic tolerances and surface finishes that directly affect patient safety and dosing accuracy.

Material selection further differentiates manufacturing pathways. Elastomers and medical-grade silicone address flexibility and sealing requirements, whereas thermoplastics deliver structural integrity; within thermoplastics, grades such as polycarbonate and polyetheretherketone provide high-temperature and chemical resistance, while polyethylene, polypropylene, and polystyrene offer processability and cost-effectiveness depending on application demands. Thermosets remain relevant where dimensional stability and thermal performance under sterilization are critical.

Application-driven priorities influence design and process choices as well. Diagnostic devices prioritize optical clarity and dimensional precision, drug delivery systems such as auto-injectors, infusion cartridges, and pre-filled syringes emphasize dosing reliability and patient usability, surgical applications require sterilization robustness, and therapeutic devices focus on long-term biocompatibility. End-user settings shape operational requirements, with ambulatory care centers and home healthcare demanding ease of use and supply-chain responsiveness, diagnostic laboratories requiring throughput and repeatability, and hospitals prioritizing sterility assurance and device lifecycle support.

Process type selection-whether insert molding, micro injection molding, multi-component molding, or standard injection molding-connects these product, material, and application imperatives to production capability. Micro molding enables the manufacture of intricate, small-form components for minimally invasive devices, insert molding allows integration of metal or pre-assembled inserts for complex assemblies, and multi-component molding reduces downstream assembly while ensuring material interfaces meet performance expectations. Understanding these interdependencies is critical for aligning manufacturing strategy with clinical and commercial objectives.

Strategic regional analysis outlining how the Americas, Europe Middle East & Africa, and Asia-Pacific dynamics inform production location, supplier strategy, and regulatory approach

Regional dynamics continue to play a defining role in shaping manufacturing strategy and commercial planning. The Americas present a mixed environment of advanced manufacturing capability, concentrated clinical demand, and regulatory oversight that emphasizes compliance and transparency. Market participants consider proximity to major healthcare systems and the logistical advantages of domestic or nearshore production as strategic levers for reducing risk and improving time to market.

The Europe, Middle East & Africa region combines sophisticated regulatory frameworks with variable market access considerations across countries, necessitating adaptive regulatory strategies and localized clinical engagement. Manufacturers operating in this broader region must balance harmonized technical standards with country-specific requirements, and many leverage regional centers of excellence for specialized production and testing to meet complex clinical and regulatory needs.

Asia-Pacific continues to be a focal point for capacity expansion, rapid manufacturing scale-up, and access to specialized material suppliers. The region's diverse industrial base supports both low-cost production and high-precision machining, making it attractive for companies seeking to optimize cost structures while accessing advanced materials and component suppliers. However, navigating regional regulatory variance, intellectual property considerations, and quality assurance expectations remains essential for firms seeking sustainable operations and long-term market penetration.

In each region, strategic decisions around facility location, supplier partnerships, and regulatory engagement are informed by local talent pools, logistical networks, and the evolving landscape of trade policies and clinical demand.

In-depth competitive view describing how specialization in materials, validated processes, and supply continuity determine differentiation and supplier selection dynamics

Competitive dynamics in medical injection molding reflect a blend of specialized niche players and larger integrated contract manufacturers that offer end-to-end services from design for manufacturability to validated production and supply. Leading firms differentiate through capabilities such as advanced material expertise, micro molding proficiency, multi-component integration, and validated regulatory pathways that shorten qualification cycles for customers. Some operators excel at highly regulated implantable components, while others focus on high-volume disposable components like syringes and single-use surgical instruments.

Strategic partnerships and vertical integration continue to shape the competitive landscape. Companies that invest in process automation, inline inspection, and data-driven quality management systems establish higher barriers to entry, particularly for complex applications requiring traceability and rigorous process control. Meanwhile, firms offering modular, scalable manufacturing solutions can attract customers seeking faster commercialization timelines and flexible capacity.

Supply reliability, documented quality systems, and experience with sterilization validation are recurrent differentiators when purchasers evaluate potential manufacturing partners. Additionally, the ability to support design optimization for manufacturability, to provide rapid prototyping into validated pilot production, and to assure continuity of supply under changing trade conditions are increasingly central to vendor selection criteria. Competitive positioning therefore rests on a combination of technical depth, regulatory competence, and supply-chain resilience.

Actionable recommendations for executives to optimize design alignment, automation investment, supplier diversification, cross-functional collaboration, and workforce capability

Industry leaders should prioritize a set of pragmatic actions to secure competitive advantage and operational resilience. First, align product design and material selection early with manufacturing capabilities, ensuring that biocompatibility, sterilization resilience, and design-for-manufacture principles are embedded from concept through validation. Early alignment reduces rework, shortens development cycles, and improves yield during scale-up.

Second, invest in process automation and real-time quality analytics to reduce variability and to meet growing regulatory expectations for traceability and control. These investments pay dividends by lowering defect rates and by enabling faster, data-supported responses to audits and post-market inquiries. Third, develop flexible sourcing strategies that incorporate dual sourcing, qualified regional suppliers, and contingency planning to mitigate trade policy and logistics disruptions. Such strategies should be complemented by contractual protections and periodic supplier performance reviews.

Fourth, foster cross-functional collaboration between R&D, regulatory, procurement, and operations to expedite supplier qualification and to ensure that product specifications remain manufacturable under multiple sourcing scenarios. Finally, prioritize workforce development and retention programs that cultivate mold design, material science, and process control expertise, because human capability remains critical to translating advanced technologies into reliable production outcomes. By executing these actions, organizations can balance innovation with regulatory compliance and supply resilience.

Detailed description of a rigorous triangulated research methodology combining primary stakeholder interviews, technical literature review, and operational case study validation

The research synthesis derives its insights from a triangulated methodology combining primary stakeholder engagement, technical document analysis, and verification against operational case studies. Primary engagements included structured interviews with manufacturing leaders, quality and regulatory professionals, and product development teams to capture firsthand perspectives on materials selection, process capability, and supply-chain pressures. These dialogues informed an understanding of the operational constraints and decision criteria that shape molding strategy.

Secondary analysis comprised a review of publicly available technical literature, regulatory guidance, and industry whitepapers to contextualize process trends, material innovations, and quality expectations. In parallel, anonymized operational case studies and factory acceptance reports were examined to verify trends in process automation, inspection regimes, and product complexity. Cross-validation steps were applied to reconcile disparate inputs and to ensure that findings reflected consistent themes rather than isolated anecdotes.

Throughout the methodology, emphasis was placed on process traceability, reproducibility of observations, and alignment with regulatory best practices. Where appropriate, sensitivity analyses of strategic choices were used to present alternative implementation pathways for manufacturers of varying scale and technical capability.

Concluding synthesis emphasizing the imperative for integrated manufacturing, regulatory readiness, and supply resilience to support future device innovation

The convergence of advanced molding processes, expanding material options, and heightened regulatory expectations defines the current trajectory for medical injection molding. Organizations that embrace process automation, invest in validated quality systems, and align material choices with sterilization and clinical requirements will be better positioned to navigate supply-chain uncertainty and to meet escalating performance demands. At the same time, flexible sourcing and regional production strategies can mitigate external risks related to trade policy and logistics.

For product teams, the imperative is clear: design for manufacturability and early engagement with qualified suppliers reduce time to clinical readiness and improve production readiness. Procurement and operations should prioritize supplier qualification, cross-validated risk mitigation plans, and investments that support traceability and rapid regulatory response. Collectively, these actions underpin a manufacturing model that is resilient, compliant, and capable of supporting next-generation medical devices.

As the sector continues to evolve, leaders must balance near-term tactical responses to trade and supply-chain dynamics with strategic investments in capability that drive long-term differentiation. In doing so, companies will be able to translate current challenges into opportunities for operational excellence and clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Injection Molding Market, by Product Type

  • 8.1. Catheters
  • 8.2. Diagnostic Components
  • 8.3. Drug Delivery Devices
  • 8.4. Implants
  • 8.5. Surgical Instruments
    • 8.5.1. Disposable Instruments
    • 8.5.2. Reusable Instruments
  • 8.6. Syringes

9. Medical Injection Molding Market, by Material Type

  • 9.1. Elastomers
  • 9.2. Silicone
  • 9.3. Thermoplastics
    • 9.3.1. Polycarbonate
    • 9.3.2. Polyetheretherketone
    • 9.3.3. Polyethylene
    • 9.3.4. Polypropylene
    • 9.3.5. Polystyrene
  • 9.4. Thermosets

10. Medical Injection Molding Market, by Process Type

  • 10.1. Insert Molding
  • 10.2. Micro Injection Molding
  • 10.3. Multi Component Molding
  • 10.4. Standard Injection Molding

11. Medical Injection Molding Market, by Application

  • 11.1. Diagnostics
  • 11.2. Drug Delivery
    • 11.2.1. Auto-Injectors
    • 11.2.2. Infusion Cartridges
    • 11.2.3. Pre-Filled Syringes
  • 11.3. Surgical
  • 11.4. Therapeutics

12. Medical Injection Molding Market, by End User

  • 12.1. Ambulatory Care Centers
  • 12.2. Diagnostic Laboratories
  • 12.3. Home Healthcare
  • 12.4. Hospitals

13. Medical Injection Molding Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Injection Molding Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Injection Molding Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Injection Molding Market

17. China Medical Injection Molding Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accumold LLC
  • 18.6. Alpine Mold Co Ltd
  • 18.7. AptarGroup Inc
  • 18.8. Becton, Dickinson and Company
  • 18.9. BMP Medical
  • 18.10. Currier Plastics Inc
  • 18.11. Freudenberg Medical
  • 18.12. Gerresheimer AG
  • 18.13. Kaysun Corporation
  • 18.14. Nolato MediTech AB
  • 18.15. Plastikon Inc
  • 18.16. Rochling Medical SE & Co KG
  • 18.17. Seasky Medical Co Ltd
  • 18.18. SMC Ltd
  • 18.19. Spectrum Plastics Group
  • 18.20. Sterling Industries Inc
  • 18.21. Terumo Corporation
  • 18.22. TPI Plastics Inc
  • 18.23. Viant Medical Corporation
  • 18.24. West Pharmaceutical Services Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL INJECTION MOLDING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL INJECTION MOLDING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REUSABLE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REUSABLE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REUSABLE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY ELASTOMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY ELASTOMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY ELASTOMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHERETHERKETONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHERETHERKETONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHERETHERKETONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYSTYRENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYSTYRENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYSTYRENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOSETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOSETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOSETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MICRO INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MICRO INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MICRO INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MULTI COMPONENT MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MULTI COMPONENT MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MULTI COMPONENT MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INFUSION CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INFUSION CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INFUSION CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 219. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 228. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 230. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)